Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Blood Glucose Monitoring Strategy

Monitoring Frequency and Technique

  • The American Diabetes Association recommends that patients on intensive insulin therapy perform capillary blood glucose monitoring 6-10 times daily, including before each meal and snack, at bedtime, occasionally 2 hours after meals, before exercise, when hypoglycemia is suspected, and after treating low blood glucose until normalized 1
  • The American Academy of Pediatrics suggests that daily fasting blood glucose measurement is the priority for patients on basal insulin only, as this reading directly informs dose adjustment of long-acting insulin 2
  • The monitoring frequency can be reduced to intermittent or infrequent monitoring schedules for patients on oral agents alone, once treatment goals are met, with the exact frequency determined by current A1C level, hypoglycemia risk of the specific medication, and patient's willingness and ability to test 2
  • Twice-daily monitoring is recommended for patients on oral agents plus basal insulin: fasting plus one additional reading (ideally 2-hour post-prandial) as long as A1C and glucose remain at goal 3
  • The American Diabetes Association recommends that all patients should test before meals (including fasting) and at bedtime until reasonable metabolic control is achieved, regardless of treatment regimen, and then reduce frequency based on the algorithm above 2

Optimal Testing Technique for Accuracy

  • The International Diabetes Federation recommends using the same glucose meter and same batch of test strips throughout, obtaining readings during periods of relative glucose stability (before meals and bedtime preferred), and verifying proper technique initially and at regular intervals 4
  • The American Diabetes Association suggests that patients must be educated on how to use the data to adjust food intake, exercise, or medications to achieve specific goals, and that structured review of glucose patterns improves A1C by an additional 0.3 percentage points compared to unstructured monitoring 1

Continuous Glucose Monitoring

  • The American Diabetes Association recommends considering continuous glucose monitoring for patients with hypoglycemia unawareness or frequent hypoglycemic episodes, patients on intensive insulin regimens not meeting glycemic targets, and those who refuse or cannot perform adequate self-monitoring 1
  • The Endocrine Society suggests that continuous glucose monitoring requires robust education, training, and ongoing support for optimal implementation 5

Improving Adherence to Blood Glucose Monitoring

Technology-Based Solutions

  • The American Diabetes Association recommends considering continuous glucose monitoring (CGM) for patients who refuse or cannot perform adequate self-monitoring, as CGM requires near-daily wearing (≥6 days/week) but eliminates the pain and inconvenience of finger-stick testing 6
  • The European Association for the Study of Diabetes suggests providing robust education, training, and ongoing support when implementing CGM, as success with CGM is critically dependent on sustained use and proper interpretation of data 7
  • The International Diabetes Federation recommends using flash glucose monitoring systems that don't require calibration and may improve compliance by avoiding frequent finger pricks, though patients still need education on when to confirm readings with capillary testing 7

Monitoring Technique

  • The American College of Endocrinology emphasizes the importance of ensuring proper technique verification, as accuracy is both instrument and user dependent, and recommends evaluating each patient's monitoring technique initially and at regular intervals 8

Implementation Algorithm

  • The American Association of Clinical Endocrinologists suggests assessing current barriers to adherence, including knowledge deficits, psychological factors, practical obstacles, or pain/cost concerns, to inform the development of a personalized intervention plan 8